Learn

Allison Jones

Home page>Infectious Diseases>Hepatitis C>The importance of diversity in clinical trials for hepatitis C

The importance of diversity in clinical trials for hepatitis C

Written byJameson Kowalczyk

Medically reviewedbyMegan Burke, MDin December 2024

Updated onOctober 23, 2024

Description

Health Equity Hepatitis

Diversity is important in clinical trials due to genetic, metabolic, social, economic, and cultural factors that contribute to disease outcomes.

Up next

The importance of diversity in clinical trials for hepatitis C

The importance of diversity in clinical trials for hepatitis C

Seeking hepatitis C treatment as a young patient of color

Seeking hepatitis C treatment as a young patient of color

Recommended for you

Treating Hep C: being honest about recreational drug useHow drug and alcohol use may interfere with getting cured of hep C.

Factors to consider when choosing a hep C treatmentHere’s what you and your healthcare provider need to consider when choosing a medication to treat hep C.

The truth about 8 Hep C mythsDispelling the top myths and misconceptions about hepatitis C.

Hep C: give yourself the best chance of being curedFollow these strategies to give yourself the best chance of success with hep C treatment.

Cookies Your privacy choices

Privacy Consumer health data privacy Terms

Copyright Sharecare © 2026